BRIONES DAVID S. (Chief Financial Officer) reported 1 transaction at ZYVERSA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/10/2022ACC: 0001213900-22-011641
DirectorOfficer· Chief Financial Officer
Since Dec 2021
+9.31K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
10.84K acquired · 1.53K disposed
Non-Derivative Transactions1
Class A Common Stock
Indirect
Shares
+10.75K
Price / share
—
Trade value
—
% of position
New position
1/6/2022
0.00→10.75K
Total
Net shares
+10.75K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 1/6/2022 | J · J | +10.75K | — | — | New position | 0.00 | 10.75K |
| Total | +10.75K | $0.00 | ||||||
Derivative Transactions2
Class B common stock
Indirect
Converts to
Class A common stock
1.53K shares
Shares
−1.53K
Strike price
Held after
55.97K
Exercisable
—
1/6/2022
Class B common stock
Indirect
Converts to
Class A common stock
156.00 shares
Shares
+91.00
Strike price
Held after
56.12K
Exercisable
—
1/6/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Class B common stock Indirect | Class A common stock1.53K shares | 1/6/2022 | J · J | −1.53K | — | 55.97K | |
| Class B common stock Indirect | Class A common stock156.00 shares | 1/6/2022 | J · J | +91.00 | — | 56.12K |